Abstract 927: A phase 2 randomized clinical trial to evaluate the safety and efficacy of pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection. Interim results from the LIMT HDV study - Hamid, S S; Etzlon, O; Lurie, Y (2017)
et al.